Atara closes $100M sale of Thousand Oaks facility
Atara Biotherapeutics, a drugmaker based in South San Francisco with a large presence in Thousand Oaks, announced April 4 that its cell therapy manufacturing facility in Thousand Oaks was purchased by Fujifilm Corp. for $100 million. The deal was first announced in January and is part of a long-term strategic supply agreement between Atara and Read More →
Sientra reports rising revenue, declining losses
Goleta-based Sientra reported record revenue for the fourth quarter and full year of 2021, and while the company still saw net losses, they were lower, the company reported March 23. Sientra, a breast implant manufacturer, had revenue of $22.6 million for the quarter, representing growth of 26.6% year-over-year, excluding discontinued operations. For the full year, Read More →
Cottage files suit against Kaiser seeking ‘tens of millions’
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
At Westmont breakfast, author Michael Lewis talks of Santa Barbara’s ‘superhero of communicable disease’
On March 6, 2020, Westmont College held its annual President’s Breakfast, which would be one of the last large indoor, public events in the region before the COVID-19 pandemic arrived. The guest was Nobel-winning psychologist and economist Daniel Kahneman. This year on March 4, at the event’s return to the Hilton Santa Barbara Beachfront Resort, Read More →
MannKind shares at lowest since 2020 after earnings report
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Arcutis share up after earnings report; company reports mounting losses but progress toward FDA approval
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen shares up after earnings report, despite growing losses
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
